Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Inland Empire Clinical Trials, Rialto, California Orange County Research Center, Tustin, California CenExel Research Centers of America, Hollywood, Florida Floridian Clinical Research, Miami Lakes, Florida Texas Liver Institute, San Antonio, Texas